Thyroid-stimulating antibody is related to graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease

Thyroid

Volumn 10, Issue 9, 2000, Pages 809-813

  Noh, J Y ^a   Hamada, N ^b   Inoue, Y ^c   Abe, Y ^d   Ito, K ^a  

^a ITO HOSPITAL   (Japan)

^b Sumire Hospital   (Japan)

^c Olympia Medical Clinic   (Japan)

^d TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GRAVES DISEASE; HORMONE BLOOD LEVEL; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; THYROID FUNCTION;

EID: 0033781882     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2000.10.809     Document Type: Article

References (25)

1. Stimulation of the human thyroid by infusions of plasma containing LATS protector
2. Pregnancy-associated changes in thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism
3. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: Potential autoantigen in Graves' ophthalmopathy
4. Thyrotropin receptor antisera for the detection of immunoreactive protein species in retroocular fibroblasts obtained from patients with Graves' ophthalmopathy
5. Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy
6. Localization and clinical significance of thyrotropin receptor mRNA expression in orbital fat and eye muscle tissues from patients with thyroid-associated ophthalmopathy
7. Presence of nonfunctional thyrotropin receptor variant transcripts in retroocular and other tissues
8. Diagnosis and management of Graves' ophthalmopathy
9. Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves' disease
10. Clinical utility of thyrotropin-receptor antibody assays: Comparison of radioreceptor and bioassay methods
11. TSH binding-inhibiting antibodies in hyperthyroidism: Relationship to clinical signs and hormone levels
12. Thyroid binding antibodies and other immunological abnormalities in patients with Graves' opthalmopathy: Effect of treatment with cyclophosphamide
13. Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy
14. Treatment of Graves' ophthalmopathy
15. Thyroid-stimulating immunoglobulins in ophthalmic Graves' disease
16. Why the NOSPECS classification of Graves' eye disease should be abandoned, with suggestions for the characterization of this disease
17. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease
18. The determination of thyroid weight in vivo with the scintigram
19. Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: Its predictive value for therapeutic outcome of immunosuppressive therapy
20. A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy
21. Bioassay of thyroid-stimulating immunoglobulin in cryopreserved human thyroid cells: Optimization and clinical evaluation
22. Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices
23. Glycosylation variants of human TSH selectively activate signal transduction pathways
24. Improvement of infiltrative ophthalmopathy in parallel with decrease of thyroid-stimulating antibody (TSAb) activity in two patients with hypothyroid Graves' disease
25. Correlation between thyroid stimulators and 3, 5, 3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: Comparison of assay by thyroid-stimulating and thyrotropin-displacing activities